NL8102947A - Gemodificeerde glucosaminoglycanen met antilipemie activiteit maar in wezen zonder anticoagulatie-effect, werkwijzen ter bereiding van deze verbindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. - Google Patents

Gemodificeerde glucosaminoglycanen met antilipemie activiteit maar in wezen zonder anticoagulatie-effect, werkwijzen ter bereiding van deze verbindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. Download PDF

Info

Publication number
NL8102947A
NL8102947A NL8102947A NL8102947A NL8102947A NL 8102947 A NL8102947 A NL 8102947A NL 8102947 A NL8102947 A NL 8102947A NL 8102947 A NL8102947 A NL 8102947A NL 8102947 A NL8102947 A NL 8102947A
Authority
NL
Netherlands
Prior art keywords
heparin
activity
hydrolysis
derivative
product
Prior art date
Application number
NL8102947A
Other languages
English (en)
Dutch (nl)
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NL8102947A publication Critical patent/NL8102947A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/02Resin hair settings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/04Dandruff

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NL8102947A 1980-06-18 1981-06-18 Gemodificeerde glucosaminoglycanen met antilipemie activiteit maar in wezen zonder anticoagulatie-effect, werkwijzen ter bereiding van deze verbindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. NL8102947A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2285180 1980-06-18
IT22851/80A IT1140999B (it) 1980-06-18 1980-06-18 Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante

Publications (1)

Publication Number Publication Date
NL8102947A true NL8102947A (nl) 1982-01-18

Family

ID=11201157

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8102947A NL8102947A (nl) 1980-06-18 1981-06-18 Gemodificeerde glucosaminoglycanen met antilipemie activiteit maar in wezen zonder anticoagulatie-effect, werkwijzen ter bereiding van deze verbindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.

Country Status (21)

Country Link
US (1) US4459289A (sv)
JP (1) JPS5952164B2 (sv)
AR (1) AR227317A1 (sv)
AU (1) AU531118B2 (sv)
BE (1) BE889275A (sv)
DE (1) DE3123806A1 (sv)
DK (1) DK267681A (sv)
ES (1) ES8203391A1 (sv)
FI (1) FI811832L (sv)
FR (1) FR2485019A1 (sv)
GB (1) GB2078768B (sv)
GR (1) GR75703B (sv)
IE (1) IE51273B1 (sv)
IT (1) IT1140999B (sv)
LU (1) LU83435A1 (sv)
NL (1) NL8102947A (sv)
NO (1) NO812055L (sv)
PH (1) PH17676A (sv)
PT (1) PT73214B (sv)
SE (1) SE8103677L (sv)
ZA (1) ZA814047B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169888B (it) * 1983-10-25 1987-06-03 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antitrombotica
JPS61250374A (ja) * 1985-04-29 1986-11-07 Honda Motor Co Ltd サイドブランチ型消音装置
IT1188184B (it) * 1985-08-14 1988-01-07 Texcontor Ets Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante
US4855139A (en) * 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5419913A (en) * 1992-03-05 1995-05-30 Podell; Howard I. Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US6242042B1 (en) 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
DE60312326T2 (de) * 2003-09-03 2007-11-08 Research In Motion Ltd., Waterloo Verfahren und Vorrichtungen zur Anzeige eines Heimnetzwerknamens
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
US8343473B2 (en) 2005-08-24 2013-01-01 Purdue Research Foundation Hydrophilized antimicrobial polymers
US20180340046A1 (en) 2017-05-27 2018-11-29 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
US20180362678A1 (en) 2017-06-16 2018-12-20 Poly Group LLC Polymeric antimicrobial surfactant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26510A (en) * 1859-12-20 andrews
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
US3320080A (en) 1964-06-05 1967-05-16 Nat Starch Chem Corp Water resistant paper coating compositions
FR2036453A5 (en) * 1969-03-14 1970-12-24 Henry Michel Cosmetic preparations additive
US3567420A (en) * 1969-04-08 1971-03-02 Shell Oil Co Use of certain polyamines as antimicrobial agents
US4080346A (en) * 1970-07-27 1978-03-21 Polaroid Corporation Novel graft copolymers having vinylbenzyl ammonium halide residues
US4144326A (en) * 1975-05-19 1979-03-13 American Cyanamid Company Oil free, water-soluble, clear creme rinse for hair
US4035146A (en) * 1975-10-20 1977-07-12 Schwarz Services International Ltd. Binding of antimicrobial compounds to a hydroxyl containing substrate with cyanuric chloride
US4131576A (en) * 1977-12-15 1978-12-26 National Starch And Chemical Corporation Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system
US4155885A (en) * 1978-04-28 1979-05-22 Merck & Co., Inc. Amphoteric graft copolymers of xanthomonas hydrophilic colloid and partially N-aminomethylated acrylamide
JPS6042762B2 (ja) * 1978-09-07 1985-09-25 ライオン株式会社 カチオン化多糖類を含有する化粧料
JPS6042763B2 (ja) * 1978-09-25 1985-09-25 ライオン株式会社 親和性の良好な化粧料
US4285973A (en) * 1979-07-20 1981-08-25 Alberto-Culver Company Liquid composition for application to the skin

Also Published As

Publication number Publication date
ZA814047B (en) 1982-06-30
IE51273B1 (en) 1986-11-26
DE3123806A1 (de) 1982-03-18
GB2078768A (en) 1982-01-13
IT1140999B (it) 1986-10-10
IE811341L (en) 1981-12-18
FI811832L (fi) 1981-12-19
AR227317A1 (es) 1982-10-15
FR2485019A1 (fr) 1981-12-24
SE8103677L (sv) 1981-12-19
LU83435A1 (fr) 1981-10-29
JPS57102903A (en) 1982-06-26
NO812055L (no) 1981-12-21
AU7187381A (en) 1981-12-24
BE889275A (nl) 1981-10-16
ES503199A0 (es) 1982-04-01
IT8022851A0 (it) 1980-06-18
ES8203391A1 (es) 1982-04-01
GB2078768B (en) 1983-10-05
PT73214B (en) 1982-07-16
AU531118B2 (en) 1983-08-11
PT73214A (en) 1981-07-01
DK267681A (da) 1981-12-19
PH17676A (en) 1984-11-02
GR75703B (sv) 1984-08-02
FR2485019B1 (sv) 1984-12-07
JPS5952164B2 (ja) 1984-12-18
US4459289A (en) 1984-07-10

Similar Documents

Publication Publication Date Title
NL8102947A (nl) Gemodificeerde glucosaminoglycanen met antilipemie activiteit maar in wezen zonder anticoagulatie-effect, werkwijzen ter bereiding van deze verbindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
JP5189137B2 (ja) グリコサミノグリカンの製造法
DE69232615T2 (de) Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen
DE60125154T2 (de) Teildesulfatierte glykosaminoglykanderivate mit antiangiogenischer aktivität und ohne antikoagulierender wirkung
JPH05508183A (ja) ヒアルロン酸の精製方法および眼科用の純粋なヒアルロン酸の分画
RU2383554C2 (ru) Сложные эфиры гиалуроновой кислоты с реином, способ их получения и композиции, содержащие эти эфиры
EP0208623A2 (fr) Utilisation de poly- et oligosaccharides pour l'obtention de médicaments actifs dans les pathologies du tissu conjonctif
CH666897A5 (fr) Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
EA013966B1 (ru) Применение эритропоэтина для лечения сахарного диабета
EP0466315A2 (en) Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
JPH03243601A (ja) 血液凝固の制御能をもつムコ多糖組成物およびその製造方法
DE60018061T2 (de) Verwendung von glykosaminoglykane zur behandlung seniler demenz
DE69334102T2 (de) Zusammenstellung zur Regulierung der Zytokinaktivität
Walzl et al. Increased cerebral perfusion following reduction of fibrinogen and lipid fractions
Alavi et al. The in vitro interactions between serum lipoproteins and proteoglycans of the neointima of rabbit aorta after a single balloon catheter injury.
JPH10503472A (ja) 筋肉処置のためのバイオポリマーの使用
JPH10503168A (ja) 神経系の損傷の処置のための置換デキストランの使用ならびにヘパラン硫酸に富む分画
EP0585371A1 (en) Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
Weigensberg et al. Biochemistry of atherosclerosis produced by cholesterol feeding, thrombosis, and injury
DE69113437T2 (de) Therapeutische Mittel für diabetisches Gangrän.
JP2010534232A (ja) 組成物および治療
JP2521083B2 (ja) ヘパリノイド活性を有する多糖体及びその製造方法並びにそれを含有する抗血液凝固剤
Kopman et al. Biochemical characterization of fracture callus proteoglycans
RU2586286C2 (ru) Применение для лечения и профилактики атеросклероза белково-пептидного комплекса (далее-бпк), полученного из эмбриональной нервной ткани или из быстрозамороженного эмбрионального мозга сельскохозяйственных копытных животных, влияющего на обратный транспорт холестерина из сосудистой стенки и профиль активации моноцитов у пациентов с выраженным атеросклерозом магистральных сосудов или с предрасположенностью к сердечно-сосудистым заболеваниям и способ профилактики и лечения пациентов с атеросклерозом артериальных сосудов и с заболеваниями, вызванными атеросклерозом магистральных и периферических сосудов головного мозга, сердца, сосудов нижних конечностей и аорты (два варианта)
US5290549A (en) Method for reducing atherosclerotic lesions in a mammal

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed